Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland)
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland). Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD. 4271
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Extracellular matrix remodelling in COPD Source: Eur Respir Rev, 29 (158) 190124; 10.1183/16000617.0124-2019 Year: 2020
Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020
Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Extracellular matrix composition in COPD Source: Eur Respir J 2012; 40: 1362-1373 Year: 2012
Role of matrix metalloproteinase in predicting of COPD stability Source: International Congress 2015 – COPD: notable points Year: 2015
Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019
Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity? Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Correlations of collagen matrix between nonspecific interstitial pneumonia and collagen disease - preliminary study Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease Source: Eur Respir J, 50 (1) 1601805; 10.1183/13993003.01805-2016 Year: 2017
Could concentration of matrix metalloproteinase-9 in serum of COPD patients change into the basic disease progress and a degree of airway obstruction? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Extracellular matrix profile of lung in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Increased concentration of matrix metalloproteinase-9 in serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
Collagen and elastin turnover increase at COPD exacerbation irrespectively its etiology Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020
Extracellular ATP as a biomarker of severity of chronic obstructive pulmonary disease Source: International Congress 2019 – Injury and repair: less is more Year: 2019
Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Sputum matrix metalloproteinase-9 and tissue inhibitor of matrix metalloprotienase-1 levels in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006
LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity Source: Eur Respir J 2012; 39: 1475-1481 Year: 2012